Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

• Richard T. Eastman,
• Jacob S. Roth,
• Kyle R. Brimacombe,
• Anton Simeonov,
• Min Shen,
• Samarjit Patnaik,
• Matthew D. Hall

Affiliations

Richard T. Eastman

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States

Jacob S. Roth

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States

Kyle R. Brimacombe

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States

Anton Simeonov

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States

Min Shen

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States

Samarjit Patnaik

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States

Matthew D. Hall

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States